Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Birth Control Methods01:22

Birth Control Methods

Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although vasectomy...
Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
Infertility in Females01:28

Infertility in Females

Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of endometrial...
Ovarian Cycle01:27

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...
Physiological Barriers01:25

Physiological Barriers

Physiological barriers are semi-permeable cellular structures restricting drug diffusion into intracellular compartments and tissues. There are six types of physiological barriers: blood endothelial, cell membrane, blood-brain, blood-cerebrospinal fluid (CSF), blood-placenta, and blood-testis barriers.
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
Gonadal and Placental Hormones01:24

Gonadal and Placental Hormones

The gonads, namely the testes in males and the ovaries in females, are pivotal in producing gonadal hormones that orchestrate the intricate processes of sexual development and reproduction.
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair growth — and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vascular risk at menopause: The importance of a cardio-gynecological program.

Maturitas·2026
Same author

[A targeted approach to cardiovascular risk in women: towards improved screening and prevention].

Medecine sciences : M/S·2026
Same author

[Establishment of the Port-Royal menopause university center. Inform, screen, and provide care].

Medecine sciences : M/S·2026
Same author

[Menopause, hormone therapy and cardiovascular risk].

Medecine sciences : M/S·2026
Same author

Risk of cardiovascular disease and mortality among women with endometriosis: A systematic review and meta-analysis.

Acta obstetricia et gynecologica Scandinavica·2025
Same author

[Menopause: towards the end of a taboo?]

La Revue du praticien·2025

Related Experiment Video

Updated: Jul 6, 2026

Methods for Studying Uterine Contributions to Pregnancy Establishment in an Ovariectomized Mouse Model
06:49

Methods for Studying Uterine Contributions to Pregnancy Establishment in an Ovariectomized Mouse Model

Published on: April 7, 2023

[Difficult contraceptions].

Claire Bricaire1, Geneviève Plu-Bureau

  • 1Médecine de la reproduction, groupe hospitalier Pitié-Salpêtrière, 75651 Paris. clairebricaire@yahoo.fr

La Revue Du Praticien
|March 11, 2008
PubMed
Summary

Selecting contraception for women with medical conditions is challenging due to potential health risks and drug interactions. More research is needed to guide safe contraceptive choices for various diseases.

Area of Science:

  • Reproductive Health
  • Pharmacology
  • Clinical Medicine

Context:

  • Contraceptive selection is complex for women with pre-existing medical conditions.
  • Potential life-threatening effects and drug interactions necessitate careful consideration.
  • Management guidelines are lacking for many specific disease states.

Purpose:

  • To review contraceptive challenges in women with specific neurological, vascular, metabolic, uterine, renal, breast, and HIV-related conditions.
  • To highlight the limitations of current scientific data for managing these cases.
  • To emphasize the need for evidence-based guidelines.

Summary:

  • This review addresses contraceptive method selection for women with epilepsy, brain tumors, migraines, prolactinomas, thrombosis, thrombophilia, arterial diseases, obesity, dyslipidemias, diabetes, fibromas, endometriosis, renal failure, breast diseases, and HIV.

More Related Videos

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
08:46

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Published on: September 16, 2021

External Cephalic Version: Is it an Effective and Safe Procedure?
08:49

External Cephalic Version: Is it an Effective and Safe Procedure?

Published on: June 6, 2020

Related Experiment Videos

Last Updated: Jul 6, 2026

Methods for Studying Uterine Contributions to Pregnancy Establishment in an Ovariectomized Mouse Model
06:49

Methods for Studying Uterine Contributions to Pregnancy Establishment in an Ovariectomized Mouse Model

Published on: April 7, 2023

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
08:46

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Published on: September 16, 2021

External Cephalic Version: Is it an Effective and Safe Procedure?
08:49

External Cephalic Version: Is it an Effective and Safe Procedure?

Published on: June 6, 2020

  • Current data are insufficient for many of these conditions, leading to non-validated management strategies.
  • The article underscores the critical need for controlled studies to inform clinical practice.

    • Impact:

    • Aims to improve the safety and efficacy of contraceptive choices for women with complex medical histories.
    • Highlights critical knowledge gaps in reproductive health for specific patient populations.
    • Advocates for further research to establish validated management protocols.